Supplementary Figure S5 from BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor–Positive Breast Cancer via Induction of miR-34a-5p
Year: 2025
Type: supplementary-materials
Abstract: Preclinical efficacy and toxicity studies of JQ1 and palbociclib.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416844778
